Bristol-Myers Squibb Company Closes Previously Announced Sale Of U.S. And Canadian Consumer Medicines Business

02-Sep-2005

Bristol-Myers Squibb Company reported that it has completed the previously announced sale of its U.S. and Canadian Consumer Medicines business to Novartis AG.

As previously disclosed, the transaction includes rights to Bristol-Myers Squibb's U.S. over-the-counter brands in Latin America, Europe, Middle East and Africa. The transfers of these rights are targeted to be completed by the end of the year.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance